This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2001 Oct 1;19(19):3908-11.

doi: 10.1200/JCO.2001.19.19.3908.

Some like it hot!

PMID: 11579110
DOI: 10.1200/JCO.2001.19.19.3908

Editorial

Some like it hot!

B D Cheson. J Clin Oncol. 2001.

. 2001 Oct 1;19(19):3908-11.

doi: 10.1200/JCO.2001.19.19.3908.

Author

PMID: 11579110
DOI: 10.1200/JCO.2001.19.19.3908

No abstract available

PubMed Disclaimer

Comment on

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.
Kaminski MS, Zelenetz AD, Press OW, Saleh M, Leonard J, Fehrenbacher L, Lister TA, Stagg RJ, Tidmarsh GF, Kroll S, Wahl RL, Knox SJ, Vose JM. Kaminski MS, et al. J Clin Oncol. 2001 Oct 1;19(19):3918-28. doi: 10.1200/JCO.2001.19.19.3918. J Clin Oncol. 2001. PMID: 11579112 Clinical Trial.

Similar articles

How and why does radioimmunotherapy work?
Macklis RM. Macklis RM. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1269-71. doi: 10.1016/j.ijrobp.2004.04.008. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275708 No abstract available.
Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
Hernandez MC, Knox SJ. Hernandez MC, et al. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1274-87. doi: 10.1016/j.ijrobp.2004.02.065. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275710 Review.
[Radioimmunotherapy in non-Hodgkin's lymphoma. With focus on anti-CD20 treatment].
de Nully Brown P, Jurlander J, Lindén O, Hansen M. de Nully Brown P, et al. Ugeskr Laeger. 2005 Oct 10;167(41):3867-9. Ugeskr Laeger. 2005. PMID: 16221425 Danish.
High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 rituximab.
Becker W, Behr T. Becker W, et al. Ann Hematol. 2001;80 Suppl 3:B130-1. doi: 10.1007/pl00022777. Ann Hematol. 2001. PMID: 11757696 Review. No abstract available.
[Radioimmunotherapy for B-cell lymphoma].
Tobinai K. Tobinai K. Rinsho Ketsueki. 2006 Jun;47(6):463-70. Rinsho Ketsueki. 2006. PMID: 16862974 Review. Japanese. No abstract available.

See all similar articles

Cited by

Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancer.
Tagawa ST, Akhtar NH, Nikolopoulou A, Kaur G, Robinson B, Kahn R, Vallabhajosula S, Goldsmith SJ, Nanus DM, Bander NH. Tagawa ST, et al. Front Oncol. 2013 Aug 26;3:214. doi: 10.3389/fonc.2013.00214. eCollection 2013. Front Oncol. 2013. PMID: 23986881 Free PMC article.
In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study.
Forrer F, Chen J, Fani M, Powell P, Lohri A, Müller-Brand J, Moldenhauer G, Maecke HR. Forrer F, et al. Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1443-52. doi: 10.1007/s00259-009-1120-2. Epub 2009 Apr 7. Eur J Nucl Med Mol Imaging. 2009. PMID: 19350237 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.